(Q34183586)

31 July 2017

1 reference

title

Gabapentin dosing for neuropathic pain: evidence from randomized, placebo-controlled clinical trials (English)

1 reference

31 July 2017

0 references

0 references

0 references

Miroslav Backonja

1

1 reference

PubMed ID

12637113

31 July 2017

Robert L Glanzman

series ordinal

2

1 reference

PubMed ID

12637113

31 July 2017

language of work or name

1 reference

1 January 2003

1 reference

31 July 2017

Clinical Therapeutics

1 reference

31 July 2017

25

1 reference

31 July 2017

1

1 reference

31 July 2017

81-104

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990011-7

31 July 2017

1 reference

7 January 2021

Painful diabetic polyneuropathy: epidemiology, pain description, and quality of life

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990011-7

7 January 2021

Psychiatric symptoms and distress differ between patients with postherpetic neuralgia and peripheral vestibular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990011-7

7 January 2021

Diabetic peripheral neuropathy and quality of life.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990011-7

7 January 2021

Psychological assessment and treatment of patients with neuropathic pain

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990011-7

7 January 2021

Herpes zoster and postherpetic neuralgia. Optimal treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990011-7

7 January 2021

A critical review of controlled clinical trials for peripheral neuropathic pain and complex regional pain syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990011-7

7 January 2021

Treatment of postherpetic neuralgia: an update

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990011-7

7 January 2021

Association of pain relief with drug side effects in postherpetic neuralgia: a single-dose study of clonidine, codeine, ibuprofen, and placebo

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990011-7

7 January 2021

Lack of analgesic effect of opioids on neuropathic and idiopathic forms of pain.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990011-7

7 January 2021

Double-blind randomized trial of tramadol for the treatment of the pain of diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990011-7

7 January 2021

Tramadol relieves pain and allodynia in polyneuropathy: a randomised, double-blind, controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990011-7

7 January 2021

Efficacy of oxycodone in neuropathic pain: a randomized trial in postherpetic neuralgia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990011-7

7 January 2021

Pharmacologic treatment of neuropathic pain

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990011-7

7 January 2021

The treatment of neuropathic pain: antidepressants and opioids

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990011-7

7 January 2021

A systematic review of antidepressants in neuropathic pain

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990011-7

7 January 2021

Excess risk of myocardial infarction in patients treated with antidepressant medications: association with use of tricyclic agents

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990011-7

7 January 2021

200 mg daily of lamotrigine has no analgesic effect in neuropathic pain: a randomised, double-blind, placebo controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990011-7

7 January 2021

Lamotrigine reduces painful diabetic neuropathy: a randomized, controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990011-7

7 January 2021

Lamotrigine for central poststroke pain: a randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990011-7

7 January 2021

Lamotrigine (Lamictal) in refractory trigeminal neuralgia: results from a double-blind placebo controlled crossover trial

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990011-7

7 January 2021

A placebo-controlled trial of lamotrigine for painful HIV-associated neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990011-7

7 January 2021

The novel anticonvulsant drug, gabapentin (Neurontin), binds to the alpha2delta subunit of a calcium channel

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990011-7

7 January 2021

Further evidence for the role of the alpha(2)delta subunit of voltage dependent calcium channels in models of neuropathic pain

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990011-7

7 January 2021

A summary of mechanistic hypotheses of gabapentin pharmacology

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990011-7

7 January 2021

Gabapentin use in neuropathic pain syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990011-7

7 January 2021

The clinical pharmacokinetics of the new antiepileptic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990011-7

7 January 2021

Inter- and intra-subject variability in gabapentin absorption and absolute bioavailability

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990011-7

7 January 2021

Gabapentin. A review of its pharmacological properties and clinical potential in epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990011-7

7 January 2021

Effects of age and gender on single-dose pharmacokinetics of gabapentin

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990011-7

7 January 2021

Gabapentin adjunctive therapy in neuropathic pain states

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990011-7

7 January 2021

Neuropathic pain: new insights, new interventions

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990011-7

7 January 2021

Spinal gabapentin is antinociceptive in the rat formalin test

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990011-7

7 January 2021

The effect of gabapentin on neuropathic pain

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990011-7

7 January 2021

Gabapentin for treatment of pain and tremor: a large case series

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990011-7

7 January 2021

Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990011-7

7 January 2021

Gabapentin in neuropathic pain syndromes: a randomised, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990011-7

7 January 2021

Gabapentin for the Treatment of Postherpetic Neuralgia: A Randomized Controlled Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990011-7

7 January 2021

Gabapentin in postherpetic neuralgia: a randomised, double blind, placebo controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990011-7

7 January 2021

The short-form McGill Pain Questionnaire

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990011-7

7 January 2021

10.1016/S0149-2918(03)90011-7

Identifiers

DOI

1 reference

31 July 2017

1 reference

PubMed ID

12637113